These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20805136)

  • 21. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss.
    Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.
    Maat W; Beiboer SH; Jager MJ; Luyten GP; Gruis NA; van der Velden PA
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1291-8. PubMed ID: 18385040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of a role of the expression of a transmembranous CD117/C-Kit receptor in the progression of uveal melanomas].
    Anurova OA; Likhvantseva VG; Vereshchagina MV
    Vestn Oftalmol; 2007; 123(5):41-4. PubMed ID: 18078058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
    Li H; Alizadeh H; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.
    Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of p16 in sporadic primary uveal melanoma.
    Lamperska K; Mackiewicz K; Kaczmarek A; Kwiatkowska E; Starzycka M; Romanowska B; Heizman J; Stachura J; Mackiewicz A
    Acta Biochim Pol; 2002; 49(2):377-85. PubMed ID: 12362979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NBS1 expression as a prognostic marker in uveal melanoma.
    Ehlers JP; Harbour JW
    Clin Cancer Res; 2005 Mar; 11(5):1849-53. PubMed ID: 15756009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
    All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inverse correlation between expression of HLA-B and c-myc in uveal melanoma.
    Blom DJ; Mooy CM; Luyten GP; Kerkvliet S; Ouwerkerk I; Zwinderman AH; Schrier PI; Jager MJ
    J Pathol; 1997 Jan; 181(1):75-9. PubMed ID: 9072006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma.
    Mooy CM; Luyten GP; de Jong PT; Luider TM; Stijnen T; van de Ham F; van Vroonhoven CC; Bosman FT
    Am J Pathol; 1995 Oct; 147(4):1097-104. PubMed ID: 7573354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma.
    Chen X; Wu Q; Depeille P; Chen P; Thornton S; Kalirai H; Coupland SE; Roose JP; Bastian BC
    Cancer Cell; 2017 May; 31(5):685-696.e6. PubMed ID: 28486107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
    Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of GNAQ mutations and reduction of cell viability in uveal melanoma cells with functionalized gold nanoparticles.
    Posch C; Latorre A; Crosby MB; Celli A; Latorre A; Vujic I; Sanlorenzo M; Green GA; Weier J; Zekhtser M; Ma J; Monico G; Char DH; Jusufbegovic D; Rappersberger K; Somoza Á; Ortiz-Urda S
    Biomed Microdevices; 2015 Feb; 17(1):15. PubMed ID: 25653058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic signaling in uveal melanoma.
    Park JJ; Diefenbach RJ; Joshua AM; Kefford RF; Carlino MS; Rizos H
    Pigment Cell Melanoma Res; 2018 Nov; 31(6):661-672. PubMed ID: 29738114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin metastases in metastatic uveal melanoma: GNAQ/GNA11 mutational analysis as a valuable tool.
    Tsianakas A; Böhm MR; Getova V; Metze D; Eter N; Spieker T; Bräuninger A; Luger T; Schiller M; Sunderkötter C
    Br J Dermatol; 2013 Jul; 169(1):160-3. PubMed ID: 23464620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic implications of the emerging molecular biology of uveal melanoma.
    Patel M; Smyth E; Chapman PB; Wolchok JD; Schwartz GK; Abramson DH; Carvajal RD
    Clin Cancer Res; 2011 Apr; 17(8):2087-100. PubMed ID: 21444680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GNAQ and GNA11 mutations in uveal melanoma.
    Shoushtari AN; Carvajal RD
    Melanoma Res; 2014 Dec; 24(6):525-34. PubMed ID: 25304237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism.
    de Lange MJ; Razzaq L; Versluis M; Verlinde S; Dogrusöz M; Böhringer S; Marinkovic M; Luyten GP; de Keizer RJ; de Gruijl FR; Jager MJ; van der Velden PA
    PLoS One; 2015; 10(9):e0138002. PubMed ID: 26368812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma.
    Bauer J; Kilic E; Vaarwater J; Bastian BC; Garbe C; de Klein A
    Br J Cancer; 2009 Sep; 101(5):813-5. PubMed ID: 19654573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.